false
0001837774
0001837774
2025-09-26
2025-09-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of
The
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September 26, 2025
Global
Innovative Platforms Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
000-56235 |
85-3816149 |
| (State
of other jurisdiction |
(Commission |
(IRS
Employer |
| of
incorporation) |
File
Number) |
Identification
No.) |
149
James Place, Maitland, Florida 32751
(Address
of principal executive office)
321-230-3739
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| |
|
None |
|
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check
mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
7.01 Regulation FD Disclosure.
On September 26, 2025, Global
Innovative Platforms Inc. (the “Company”) posted an updated investor presentation on its website. A copy of the Company’s
presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item
7.01. The presentation will be made available on the Company’s website at www.vetbreath.com under Investor Relations.
The information contained on the Company’s website shall not be deemed part of this Current Report on Form 8-K.
The information contained
in this Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject
to the liabilities of that Section and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended,
or the Exchange Act except to the extent expressly stated in such filing.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number |
Description |
| 99.1 |
Investor Presentation in use beginning September 26, 2025 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
| September 26, 2025 |
Global Innovative Platforms Inc. |
| |
|
| |
/s/ Andrew Brown |
| |
Name: Andrew Brown |
| |
Title: Chief Executive Officer and Chief Financial Officer |
